Engineering Heart Tissue for In Vitro and In Vivo Studies

  • Wolfram-Hubertus Zimmermann
  • Ivan Melnychenko
  • Michael Didié
  • Ali El-Armouche
  • Thomas Eschenhagen


Cardiac Myocytes Casting Mould Cell Culture Technique Engineer Heart Tissue Chick Embryo Extract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, and Vunjak-Novakovic G: Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64:580–589, 1999CrossRefPubMedGoogle Scholar
  2. Communal C, Huq F, Lebeche D, Mestel C, Gwathmey JK, and Hajjar RJ: Decreased efficiency of adenovirus-mediated gene transfer in aging cardiomyocytes. Circulation 107:1170–1175, 2003CrossRefPubMedGoogle Scholar
  3. Coon HG and Cahn RD: Differentiation in vitro: effects of Sephadex fractions of chick embryo extract. Science 153:1116–1119, 1966PubMedGoogle Scholar
  4. El-Armouche A, Rau T, Zolk O, Ditz D, Pamminger T, Zimmermann WH, Jackel E, Harding SE, Boknik P, Neumann J, and Eschenhagen T: Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. Faseb J, 2003Google Scholar
  5. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wakatsuki T, and Elson EL: Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb J 11:683–694, 1997PubMedGoogle Scholar
  6. Eschenhagen T, Fink C, Rau T, Remmers U, Weil J, Zimmermann WH, Aigner S, Eppenberger HM, Wakatsuki T, and Elson EL: Transfection studies using a new cardiac 3D gel system. In: Molecular Approaches to Heart Failure Therapy; Ed: Hasenfuss G, Marbán E; Springer Verlag; Darmstadt, 2000Google Scholar
  7. Eschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, and Zimmermann WH: 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97Suppl 1:I146–152, 2002PubMedGoogle Scholar
  8. Fechner H, Noutsias M, Tschoepe C, Hinze K, Wang X, Escher F, Pauschinger M, Dekkers D, Vetter R, Paul M, Lamers J, Schultheiss HP, and Poller W: Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation 107:876–882, 2003CrossRefPubMedGoogle Scholar
  9. Fink C, Ergun S, Kralisch D, Remmers U, Weil J, and Eschenhagen T: Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Faseb J 14:669–679, 2000PubMedGoogle Scholar
  10. Gepstein L: Derivation and potential applications of human embryonic stem cells. Circ Res 91:866–876, 2002CrossRefPubMedGoogle Scholar
  11. Kofidis T, Akhyari P, Boublik J, Theodorou P, Martin U, Ruhparwar A, Fischer S, Eschenhagen T, Kubis HP, Kraft T, Leyh R, and Haverich A: in vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124:63–69, 2002CrossRefPubMedGoogle Scholar
  12. Kolodney MS and Elson EL: Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 268:23850–23855, 1993PubMedGoogle Scholar
  13. Langer R and Vacanti JP: Tissue engineering. Science 260:920–926, 1993PubMedGoogle Scholar
  14. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, and Cohen S: Bio-engineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102:III56–61, 2000PubMedGoogle Scholar
  15. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, and Yau TM: Survival and function of bio-engineered cardiac grafts. Circulation 100:II63–69, 1999PubMedGoogle Scholar
  16. Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Borries M, Niroomand F, Pieske B, Janssen PM, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Katus HA, and Remppis A: S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A 98:13889–13894, 2001CrossRefPubMedGoogle Scholar
  17. Reinlib L and Field L: Cell transplantation as future therapy for cardiovascular disease? A workshop of the National Heart, Lung, and Blood Institute. Circulation 101:E182–187, 2000PubMedGoogle Scholar
  18. Souren JE, Schneijdenberg C, Verkleij AJ, and Van Wijk R: Factors controlling the rhythmic contraction of collagen gels by neonatal heart cells. In Vitro Cell Dev Biol 28A:199–204, 1992PubMedGoogle Scholar
  19. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, and Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349–363, 2002CrossRefPubMedGoogle Scholar
  20. van Luyn MJ, Tio RA, Gallego y van Seijen XJ, Plantinga JA, de Leij LF, DeJongste MJ, and van Wachem PB: Cardiac tissue engineering: characteristics of in unison contracting two-and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 23:4793–4801, 2002PubMedGoogle Scholar
  21. Webster KA and Bishopric NH: Molecular regulation of cardiac myocyte adaptations to chronic hypoxia. J Mol Cell Cardiol 24:741–751, 1992CrossRefPubMedGoogle Scholar
  22. Zimmermann WH: Entwicklung und Charakterisierung einer neuen Methode zur Herstellung von künstlichem Herzgewebe aus Herzmuskelzellen neonataler Ratten. Dissertation at the University of Hamburg, Germany, 2000Google Scholar
  23. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, and Eschenhagen T: Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106–114, 2000CrossRefPubMedGoogle Scholar
  24. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, and Eschenhagen T: Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106:I151–157, 2002aPubMedGoogle Scholar
  25. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, and Eschenhagen T: Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223–230, 2002bCrossRefPubMedGoogle Scholar
  26. Zimmermann WH and Eschenhagen T: Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8:259–269, 2003CrossRefPubMedGoogle Scholar
  27. Zimmermann WH, Melnychenko I, Eschenhagen T: Engineered heart tissue for regeneration od diseased hearts. Biomaterials 25: 1639–1647, 2004PubMedGoogle Scholar
  28. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S, and Eschenhagen T: Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293:1377–1382, 2002CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Wolfram-Hubertus Zimmermann
    • 1
  • Ivan Melnychenko
    • 1
  • Michael Didié
    • 1
  • Ali El-Armouche
    • 1
  • Thomas Eschenhagen
    • 1
  1. 1.Zentrum für Experimentelle Medizin, Institut für Experimentelle und Klinische PharmakologieUniversitätsklinikum Hamburg-EppendorfHamburgGermany

Personalised recommendations